Semi-permissive replication and functional aspects of the immune response in a cotton rat model of human parainfluenza virus type 3 infection
- PMID: 8760420
- DOI: 10.1099/0022-1317-77-8-1739
Semi-permissive replication and functional aspects of the immune response in a cotton rat model of human parainfluenza virus type 3 infection
Abstract
A cotton rat (Sigmodon fulviventer) model of human parainfluenza virus type 3 (HPIV-3) infection was used to study patterns of HPIV-3 replication in naive and immune hosts. Growth curves revealed that nasal and pulmonary tissues of naive animals were semi-permissive for virus replication, with amounts of progeny virus proportional to inoculating doses. In naive animals there was a total eclipse in nasal tissues beginning 4 h after inoculation. By contrast, there was only partial eclipse of virus in pulmonary tissues, most pronounced at 1 h after inoculation. Immune animals demonstrated a delayed eclipse in pulmonary tissues upon rechallenge. Infection with very low doses of HPIV-3 induced complete protection against high-dose challenge in the absence of systemic neutralizing antibody, suggesting a significant role for other systemic or local immune effectors.
Similar articles
-
Pathogenesis of human parainfluenza virus 3 infection in two species of cotton rats: Sigmodon hispidus develops bronchiolitis, while Sigmodon fulviventer develops interstitial pneumonia.J Virol. 1991 Jan;65(1):103-11. doi: 10.1128/JVI.65.1.103-111.1991. J Virol. 1991. PMID: 1845878 Free PMC article.
-
African green monkeys provide a useful nonhuman primate model for the study of human parainfluenza virus types-1, -2, and -3 infection.Vaccine. 2000 May 8;18(22):2462-9. doi: 10.1016/s0264-410x(99)00575-7. Vaccine. 2000. PMID: 10738104
-
Recombinant type 5 adenoviruses expressing bovine parainfluenza virus type 3 glycoproteins protect Sigmodon hispidus cotton rats from bovine parainfluenza virus type 3 infection.J Virol. 1995 Jul;69(7):4308-15. doi: 10.1128/JVI.69.7.4308-4315.1995. J Virol. 1995. PMID: 7769692 Free PMC article.
-
Parainfluenza virus infection among adults hospitalized for lower respiratory tract infection.Clin Infect Dis. 1999 Jul;29(1):134-40. doi: 10.1086/520142. Clin Infect Dis. 1999. PMID: 10433576
-
Development of a novel subunit vaccine that protects cotton rats against both human respiratory syncytial virus and human parainfluenza virus type 3.J Gen Virol. 1993 Sep;74 ( Pt 9):1995-9. doi: 10.1099/0022-1317-74-9-1995. J Gen Virol. 1993. PMID: 8397289
Cited by
-
Protective antibodies against human parainfluenza virus type 3 infection.MAbs. 2021 Jan-Dec;13(1):1912884. doi: 10.1080/19420862.2021.1912884. MAbs. 2021. PMID: 33876699 Free PMC article.
-
Exploring the impact of inoculum dose on host immunity and morbidity to inform model-based vaccine design.PLoS Comput Biol. 2018 Oct 1;14(10):e1006505. doi: 10.1371/journal.pcbi.1006505. eCollection 2018 Oct. PLoS Comput Biol. 2018. PMID: 30273336 Free PMC article.
-
AdAPT-001, an oncolytic adenovirus armed with a TGF-β trap, overcomes in vivo resistance to PD-L1-immunotherapy.Am J Cancer Res. 2022 Jul 15;12(7):3141-3147. eCollection 2022. Am J Cancer Res. 2022. PMID: 35968324 Free PMC article.
-
Initial Inoculum and the Severity of COVID-19: A Mathematical Modeling Study of the Dose-Response of SARS-CoV-2 Infections.Epidemiologia (Basel). 2020 Oct 21;1(1):5-15. doi: 10.3390/epidemiologia1010003. Epidemiologia (Basel). 2020. PMID: 36417207 Free PMC article.
-
Crossing the scale from within-host infection dynamics to between-host transmission fitness: a discussion of current assumptions and knowledge.Philos Trans R Soc Lond B Biol Sci. 2015 Aug 19;370(1675):20140302. doi: 10.1098/rstb.2014.0302. Philos Trans R Soc Lond B Biol Sci. 2015. PMID: 26150668 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
